Alternative Medicine

Olfactive Biosolutions Files Patent to Repurpose Food Molecules to Safely, Inexpensively Regulate Blood Pressure

Retrieved on: 
Tuesday, April 2, 2024
Technology, FDA, Fitness & Nutrition, Clinical Trials, Other Health, Biotechnology, Alternative Medicine, Pharmaceutical, Health, Artificial Intelligence, Food, Dopamine, Drink, Blood pressure, Patent, Weight loss, Serotonin, Pharmaceutical industry

The Protenx patent also allows for administration including but not limited to topically, sublingual lozenges, inhaled or administered in multiple other ways.

Key Points: 
  • The Protenx patent also allows for administration including but not limited to topically, sublingual lozenges, inhaled or administered in multiple other ways.
  • “We are replacing prescription pharmaceuticals with common food molecules, creating a new, inexpensive, easy-to-digest category of health care solutions,” said Nils Lommerin, President and CEO of Olfactive Biosolutions.
  • “We believe regulating blood pressure is an important aspect of people’s health, and we are excited to have filed a new patent for Protenx to safely and inexpensively replace pharmaceuticals that currently control blood pressure in millions of people worldwide.
  • “Adding the patent for controlling blood pressure to the Protenx products for weight loss, with new products for other conditions to come, establishes us as the leader in the food as pharmaceuticals category of health care.

New Survey Reveals Majority of Americans Agree, Cannabis Home Grow Should Be Legal

Retrieved on: 
Tuesday, April 2, 2024
Alternative Medicine, Cannabis, Retail, Health, Tobacco, Natural Resources, Pharmaceutical, Seed, Legislation, Habit, Nature, Vegetable, RQS, Plant, F1, Seedling, The Harris Poll, Food, Safety, Drug

The 2024 survey of Americans 21 and older conducted online by The Harris Poll on behalf of Royal Queen Seeds (RQS), one of the world's largest and most trusted cannabis seed banks, shows that 59% of Americans agree that all Americans should have the right to legally grow cannabis at home.

Key Points: 
  • The 2024 survey of Americans 21 and older conducted online by The Harris Poll on behalf of Royal Queen Seeds (RQS), one of the world's largest and most trusted cannabis seed banks, shows that 59% of Americans agree that all Americans should have the right to legally grow cannabis at home.
  • Findings suggest that home cultivation is as key to successful cannabis legalization legislation as regulated sales or record expungement.
  • The nationally representative study, conducted in February 2024, surveyed more than 2,000 adults ages 21 and older, among whom 713 are cannabis consumers.
  • Survey participants shared their thoughts on cannabis home grow laws as well as habits and purchasing patterns tied to 4/20, the largest cannabis sales day of the year.

Celebrate Vitacost’s 30th Anniversary With the $30K Giveaway Sweepstakes

Retrieved on: 
Monday, April 1, 2024
Mental Health, Vitamins, Supplements, Fitness & Nutrition, Specialty, Alternative Medicine, Food, Beverage, Health, Retail, Online Retail, SMS, Vitacost, Vitamin, Drawing, Auction

Vitacost.com, a leading online retailer of health and wellness products, is celebrating its 30th anniversary with the launch of a $30K Giveaway sweepstakes.

Key Points: 
  • Vitacost.com, a leading online retailer of health and wellness products, is celebrating its 30th anniversary with the launch of a $30K Giveaway sweepstakes.
  • “The $30K Giveaway is an exciting way of showing genuine appreciation for our customers.”
    Three $10,000 cash prizes will be up for grabs.
  • For more information about the $30K Giveaway sweepstakes, including official rules and entry details, visit vitacost.com/sweepstakes .
  • In addition to the $30K Giveaway, Vitacost is celebrating its 30th anniversary with an unprecedented event: 30 Thursdays.

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

Retrieved on: 
Monday, April 1, 2024
Other Health, Banking, General Health, Cannabis, Professional Services, Pharmaceutical, Medical Devices, Natural Resources, Insurance, Alternative Medicine, Finance, Health, Annual report, Growth, Partnership, Patient, GMP, TYSON, Government, 20F, Drug

(NASDAQ: INCR) (TASE: INCR) ("InterCure" or the “Company”) today announced preliminary results for the full year of 2023.

Key Points: 
  • (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the “Company”) today announced preliminary results for the full year of 2023.
  • Annual revenue for 2023 is estimated at NIS 351 million, and revenue for the H2 2023 is estimated at NIS 140 million.
  • EBITDA for 2023 is estimated at over NIS 50 Million, and H2 2023’s EBITDA is estimated to reach over NIS 20 million and over 14% of revenues.
  • Both Q3&Q4 2023 represents the fourteenth & fifteenth consecutive quarter of profitability for InterCure, with both Q3&Q4 showing a positive EBITDA and profit from operations.

Naropa University Launches Pioneering Psychedelic Minor  

Retrieved on: 
Friday, March 29, 2024
Alternative Medicine, Education, Health, Other Education, Pharmaceutical, University, Interdisciplinarity, NCPS, Research, Mindfulness, Learning, Literature, Humanities, Heel, Religious studies, History, Policy, Student, Regulatory Agencies, Psychology, Autumn, Licensure, Curriculum, Outline of counseling, Art therapy, Movement, Naropa University, Nursing

Naropa University (Naropa), the birthplace of the modern mindfulness movement and one of the nation’s only higher educational institutions to offer a postgraduate certificate in psychedelic-assisted therapies , is now launching one of the first psychedelic minor programs in the country for undergraduate students of all majors.

Key Points: 
  • Naropa University (Naropa), the birthplace of the modern mindfulness movement and one of the nation’s only higher educational institutions to offer a postgraduate certificate in psychedelic-assisted therapies , is now launching one of the first psychedelic minor programs in the country for undergraduate students of all majors.
  • Launching in the Fall of 2024, the 12-credit BA Psychedelic Studies Minor provides a humanities and social science-based approach to studying psychedelics.
  • “Psychedelic minor graduates will be well prepared for a career in psychedelic-assisted therapy, with both Naropa University’s rigorous academic education and our singularly unique contemplative pedagogy woven throughout the curriculum,” said Naropa University President Charles G. Lief, J.D.
  • "The minor in psychedelic studies integrates existing contemplative coursework across diverse disciplines with the latest scholarship on psychedelic studies,” said Betsy Gonzalez Blohm, Dean of Naropa College and the Graduate Collective.

TRP Unveils First Two Dispensaries on the Florida West Coast, Celebrating With a Cookies Tampa City Takeover on March 30th

Retrieved on: 
Thursday, March 28, 2024
Alternative Medicine, Cannabis, Retail, Health, Tobacco, Natural Resources, Specialty, Growth, MSA, Partnership, Patient, The New York Times, RSVP, ID, Drug

To celebrate, TRP is hosting a Cookies Tampa City Takeover on Saturday, March 30th.

Key Points: 
  • To celebrate, TRP is hosting a Cookies Tampa City Takeover on Saturday, March 30th.
  • This growth highlights the burgeoning demand for cannabis products and services in the state, providing a compelling backdrop for Cookies Tampa's City Takeover.
  • “The unveiling of both Cookies Tampa locations signifies a pivotal moment for TRP, the Cookies brand, and our mission to elevate access to premium cannabis products,” expressed TRP CEO, Brandon Johnson.
  • This financial success reinforces the strategic significance of Cookies Tampa as it enters Florida’s west coast market.

Texas Original Announces Opening of Sugar Land Location, Launches New RSO Gummies

Retrieved on: 
Wednesday, March 27, 2024
Vitamins, Supplements, Tobacco, Cannabis, Alternative Medicine, General Health, Pharmaceutical, Health, Retail, Natural Resources, Oncology, Dark, Epilepsy, Spasticity, Cannabinoid, RSO, Patient, Flavonoid, Cancer, Terpene, Protein, Originality, THC, Physician, PTSD, Diabetic neuropathy, Medicinal plants

Texas Original , Texas’ leading medical cannabis provider, today announced the opening of its newest prescription pickup location in Sugar Land, Texas.

Key Points: 
  • Texas Original , Texas’ leading medical cannabis provider, today announced the opening of its newest prescription pickup location in Sugar Land, Texas.
  • Texas Original also announced the launch of its new Pineapple Gummies, a 20 mg THC-only product made with Rick Simpson Oil (RSO).
  • Alongside the company’s recently launched Dark Chocolate Bites and RSO Tincture, Texas Original’s Pineapple Gummies are among the first medical cannabis products in the state—and the first gummy product—to incorporate RSO.
  • Texans can obtain medical cannabis prescriptions through online clinics or local physicians registered with the Compassionate Use Registry of Texas.

Rip Road Announces ISO 13485:2016 Certification

Retrieved on: 
Wednesday, March 27, 2024
Software, Pharmaceutical, Data Management, Apps, Applications, Medical Devices, Technology, Security, Health Technology, Biotechnology, Wearables, Mobile Technology, Alternative Medicine, Health, Certification, Organization, Patient, Sale, Medical device, Quality management system, QMS, Safety, Providers, Multimedia, ISO, Medicine

Rip Road, a leading provider of Software as a Medical Device (SaMD) companion applications for biologic medications and medication delivery devices, announced today that it has received certification of their Quality Management System (QMS) to the requirements of ISO 13485:2016.

Key Points: 
  • Rip Road, a leading provider of Software as a Medical Device (SaMD) companion applications for biologic medications and medication delivery devices, announced today that it has received certification of their Quality Management System (QMS) to the requirements of ISO 13485:2016.
  • View the full release here: https://www.businesswire.com/news/home/20240327209932/en/
    ISO 13485:2016 certification demonstrates Rip Road’s adherence to regulatory standards and commitment to safety, data security, and effective engineering processes.
  • (Graphic: Business Wire)
    Rip Road’s pharmaceutical and medical device clients build their SaMD companion applications on the highly configurable Rip Road Platform.
  • "This certification represents an important milestone for Rip Road and reflects our commitment to quality in providing best-in-class SaMD companion applications for our clients," said Eric Leven, president of Rip Road.

Novo Integrated Sciences Provides Update on Certain Current Actions and Events

Retrieved on: 
Tuesday, March 26, 2024
Alternative Medicine, Health, Other Health, Other Science, Managed Care, General Health, Science, Transfer, Assignment, SPA, VAP, District court, United States district court, Acquisition, Successor, Black sheep, Procurement, Gold, Collection, Court

2:19-cv-04299 VAP (JPRx) to acquire a certain collection of 43 gemstones, 42 of which are certified by the Gemological Institute of America, (the “Ophir Collection”), for $60,000,000.

Key Points: 
  • 2:19-cv-04299 VAP (JPRx) to acquire a certain collection of 43 gemstones, 42 of which are certified by the Gemological Institute of America, (the “Ophir Collection”), for $60,000,000.
  • On December 1, 2023, the Court approved the Ophir Agreement.
  • Within two business days following the Company’s execution of the Ophir Agreement, the Company was required to, and did, deposit $25,000 with the Successor Receiver.
  • The UCC-3 filing provides for the partial assignment and transfer of the full face-value of the Bond to Novo for a maximum term of 15-years without the benefit of annual interest.

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

Retrieved on: 
Friday, March 22, 2024
Alternative Medicine, Cannabis, Health, Other Health, Natural Resources, General Health, Pharmaceutical, Narcotic, Federal republic, Cannabis Act, Patient, Drug

On the backdrop of this monumental development, InterCure expects to launch a series of products in Germany in the coming months.

Key Points: 
  • On the backdrop of this monumental development, InterCure expects to launch a series of products in Germany in the coming months.
  • While the Cannabis Act deals with all types of cannabis, it is poised to have a uniquely significant impact on the medical cannabis sector.
  • This sets the stage for expected significant expansion of the medical cannabis market in Germany.
  • As a leader in pharmaceutical Cannabis, we are closely watching these developments including the potential rescheduling of Cannabis in the United States, and plan to advance our global footprint, expecting to launch our products in Germany in the coming months.